Pathophysiology of DKA and Euglycemic DKA
Both classic DKA and euglycemic DKA share the same fundamental metabolic derangement—insulin deficiency coupled with counterregulatory hormone excess driving ketogenesis—but differ critically in their glucose handling, with euglycemic DKA maintaining near-normal glucose levels (typically <200-250 mg/dL) due to preserved urinary glucose excretion or carbohydrate deficit states.
Classic Diabetic Ketoacidosis (DKA)
Core Hormonal Derangement
The pathophysiology centers on reduced net effective insulin action combined with elevated counterregulatory hormones (glucagon, catecholamines, cortisol, and growth hormone) 1. This hormonal imbalance triggers a cascade of metabolic consequences:
Glucose metabolism disruption:
- Increased hepatic and renal glucose production
- Impaired peripheral glucose utilization
- Results in marked hyperglycemia (typically >250 mg/dL)
- Parallel increases in extracellular osmolality 1
Ketone body production:
- Insulin deficiency plus counterregulatory hormone excess stimulates adipose tissue lipolysis
- Free fatty acids released into circulation
- Unrestrained hepatic fatty acid oxidation produces ketone bodies (β-hydroxybutyrate and acetoacetate)
- Accumulation causes ketonemia and metabolic acidosis 1, 2
Fluid and electrolyte losses:
- Hyperglycemia-induced glycosuria drives osmotic diuresis
- Progressive loss of water, sodium, potassium, and other electrolytes
- Leads to profound dehydration and electrolyte depletion 1
Clinical Evolution
DKA typically evolves rapidly, within 24 hours in most cases, though occasionally develops more acutely without warning 1. The mortality rate is approximately 5% in experienced centers, worsening significantly with extremes of age, coma, or hypotension 1.
Euglycemic Diabetic Ketoacidosis
Distinguishing Pathophysiology
Euglycemic DKA represents a diagnostic challenge because it presents with the metabolic acidosis and ketosis of DKA but without the expected severe hyperglycemia 3, 4. The key pathophysiologic difference involves:
Carbohydrate deficit state:
- Relative or absolute carbohydrate deficit despite insulin deficiency
- Milder degree of insulin deficiency or resistance compared to classic DKA
- Increased glucagon/insulin ratio still drives ketogenesis 5
- Enhanced urinary glucose excretion prevents hyperglycemia accumulation 4
Preserved glucose excretion mechanisms:
- SGLT2 inhibitors are the most common modern precipitant, causing obligatory glucosuria that prevents glucose accumulation despite ketogenesis 6, 7
- The drug-induced carbohydrate deficit signals cellular fuel shortage, triggering the same counterregulatory hormone response as classic DKA 6
- Metabolic shift from glucose to lipid utilization drives ketone body production 6
Additional Precipitating Contexts
Beyond SGLT2 inhibitors, euglycemic DKA occurs in specific clinical scenarios where glucose availability is limited 4, 5:
- Starvation states (reduced oral intake, fasting)
- Pregnancy (increased metabolic demands, insulin resistance)
- Chronic liver disease (impaired gluconeogenesis)
- Alcohol use (depleted glycogen stores, impaired gluconeogenesis)
- Bariatric surgery (reduced carbohydrate absorption)
- Insulin pump failure (in context of reduced carbohydrate intake)
Diagnostic Criteria Distinction
Euglycemic DKA is defined by 4, 5:
- Serum glucose **<200-250 mg/dL** (versus >250 mg/dL in classic DKA)
- Anion gap metabolic acidosis
- Ketonemia/ketonuria
- pH typically <7.3 with low bicarbonate
Critical Clinical Pitfall
The absence of marked hyperglycemia in euglycemic DKA frequently delays diagnosis, as clinicians may not suspect DKA when glucose is near-normal 3, 5. This diagnostic delay worsens outcomes. The condition requires high clinical suspicion in diabetic patients presenting with:
- Non-specific GI symptoms (nausea, vomiting)
- Malaise or fatigue
- Known SGLT2 inhibitor use
- Recent starvation, illness, surgery, or pregnancy 7
Always check serum or urine ketones in diabetic patients with metabolic acidosis regardless of glucose level 7. Blood ketone meters significantly improve diagnostic accuracy and speed.
Shared Final Common Pathway
Despite the glucose difference, both conditions produce the same life-threatening metabolic acidosis through ketone body accumulation 2. The reduction in insulin-glucagon ratio signals cellular fuel shortage, promoting lipolysis and hepatic β-oxidation of fatty acids, yielding acetyl-CoA that converts to ketone bodies 2. This fundamental mechanism explains why treatment principles remain similar—both require insulin to suppress ketogenesis, though euglycemic DKA requires concurrent dextrose administration to prevent hypoglycemia during insulin therapy 4, 5.